The study identifies upregulated endomembrane system organization proteins in MCI-A(-) and AD but provides no mechanistic explanation for why this pathway is specifically activated in amyloid-positive states. Understanding this mechanism could reveal how peripheral amyloid pathology manifests in platelets and inform biomarker development. Gap type: unexplained_observation Source paper: Platelet proteomic signatures of amyloid β-positive mild cognitive impairment and Alzheimer's disease. (2026, Molecular brain, PMID:41904574)
Landscape Summary: What mechanisms drive endomembrane system organization upregulation specifically in amyloid-positive MCI and AD platelets? is a 0.79 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What mechanisms drive endomembrane system organization upregulation specifically in amyloid-positive MCI and AD platelets? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: